BMS Follows Merck’s Lead, Sues Government Over Drug Pricing Negotiation

Friday, Bristol Myers Squibb filed a lawsuit against the Biden administration, alleging that an upcoming Medicare drug negotiation program violates the First and Fifth Amendments of the U.S. Constitution, according to a report by Reuters.